Bringing the fundamentals into focus…
Back to AngioDynamics, Inc.
How AngioDynamics, Inc. stacks up
ANGO · against 409 other Healthcare companies of similar size
Growth
31/ 100
Below the middle of the pack.
Ranked #245 of 410 · scores higher than 39% of peers
Bars: peers in each 10-point band of the growth score48 peers with a growth score of 30–39, including ANGO · Click a bar to see the companies
Why growth scores 31?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over three years: weaker than 73% of peers. 3-year revenue growth: -1.1% vs peer median 5.8%
- Revenue growth is close to the peer norm. Revenue growth: 8.2% vs peer median 6.1%
Metric by metric
Position: dot = ANGO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ANGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 423 reported | 8.2% | 3.0% | 65% | 33% | |
| Earnings per share growthHigher is better · 211 reported | Not reported | 3.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 401 reported | -1.1% | 3.2% | 38% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ANGO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 240 | 533M USD | 32 | 36 | |
| 245 | 2.8B CNY (≈$394M) | 31 | 39 | |
| 245 | 2.2B CNY (≈$310M) | 31 | 39 | |
| 245 | 63.5B JPY (≈$432M) | 31 | 57 | |
| 245 | 493M USD | 31 | 38 | |
| 245 | 302M USD | 31 | 17 | |
| 250 | 3.8B HKD (≈$486M) | 30 | 56 | |
| 250 | 3.3B CNY (≈$463M) | 30 | 26 | |
| 250 | 3.6B CNY (≈$507M) | 30 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score